



<HTML>
<HEAD>
   <TITLE>exhibit9901</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<table width="100%"  border="0" cellspacing="0" cellpadding="0">
     <tr>
          <td width="33%" valign="top"><b><font size=1 face="sans-serif">Shire Pharmaceuticals
          Group plc<br>
</font></b><font size=1 face="sans-serif">Hampshire International Business Park, <br>
Chineham, Basingstoke RG24 8EP UK <br>
Tel +44 1256 894000 Fax +44 1256 894708<br>
http://www.shire.com</font></td>
          <td>&nbsp;</td>
          <td align="right"><img src="ex9901x2x1.jpg"></td>
     </tr>
     <tr>
          <td width="33%">&nbsp;</td>
          <td>&nbsp;</td>
          <td>&nbsp;</td>
     </tr>
</table>

<P>
<B></B></P>
<P>&nbsp;</P>
<TABLE><TR>
  <TD nowrap>
<FONT size=2 face="sans-serif">24 December 2004</FONT></TD>
</TR></TABLE>
<br>
<TABLE><TR><TD nowrap>
<FONT size=2 face="sans-serif">Shire Pharmaceuticals Group plc (the "Company")</FONT></TD></TR></TABLE>
<P><FONT SIZE="2" face="Arial,Helvetica,sans-serif">The Company announces
    that it was notified on 24 December 2004 under Sections 198 to 202 of the
    Companies Act that on 23 December 2004 Franklin Resources, Inc. and its affiliates
    had holdings managed on behalf of investment clients of 62,872,992 ordinary
    shares of &pound;0.05p each in the capital of the Company. These holdings
represent 12.966 per cent of the issued ordinary share capital of the Company.</FONT></P>
<P>
<FONT size=2 face="sans-serif">T May </FONT><br>

<FONT size=2 face="sans-serif">Company Secretary</FONT></P>
<P>
<B><FONT size=2 face="sans-serif">For further information please contact:</FONT></B></P>
<P>
<B><FONT size=2 face="sans-serif">Investor Relations </FONT></B><FONT size=2 face="sans-serif"> </FONT></P>
<P>
<FONT size=2 face="sans-serif">Cl&eacute;a Rosenfeld               &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+44 1256 894 160 </FONT></P>
<br>
<P>
<B><FONT size=2 face="sans-serif">Notes to editors</FONT></B></P>
<P>
<B><FONT size=2 face="sans-serif">Shire Pharmaceuticals Group plc</FONT></B></P>
<P>
<FONT size=2 face="sans-serif">Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing
products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the world&#146;s key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug
delivery unit in the US. </FONT></P>
<P>
<FONT size=2 face="sans-serif">For further information on Shire, please visit the Company&#146;s website: </FONT><U><FONT color="#000065" size=2 face="sans-serif">www.shire.com</FONT></U><FONT size=2 face="sans-serif">.</FONT></P>

<HR noshade align="center" width="100%" size=2>

</BODY>

</HTML>


